Assessing the Benefits of Artificial Proprioception on Walking Speed and Turning Control in Lower-Limb Amputation
Revista Mexicana de Ingeniería Biomédica · 29.09.2026 · 47 (3) · e1686
DOI: 10.17488/rmib.47.3.1686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Mexicana de Ingeniería Biomédica, online erschienen am 29.09.2026. Verfasst von Octavio Diaz-Hernandez. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This pilot study evaluated the potential impact of artificial proprioception (AP) using plantar-pressure-derived vibrotactile feedback on spatiotemporal gait parameters, symmetry, and trunk stability during straight (10MWT) and figure-of-eight (F8WT) walking in unilateral transtibial amputees. Seven male amputees (52.3 ± 10.1 years) completed both tasks under INACTIVE (no vibration) and ACTIVE (dermatome-mapped proportional feedback) conditions in a within-subject repeated-measures design. Parameters were obtained from plantar sensors and a lumbar IMU; paired t-tests, Wilcoxon tests, and repeated-measures ANOVA were used (α=0.05). AP was associated with a significant reduction in step-time variability (CV: -27.6%, p
Zitieren
APA
Diaz-Hernandez, O. (2026). Assessing the Benefits of Artificial Proprioception on Walking Speed and Turning Control in Lower-Limb Amputation. Revista Mexicana de Ingeniería Biomédica, 47(3), e1686. https://doi.org/10.17488/rmib.47.3.1686
Vancouver
Diaz-Hernandez O. Assessing the Benefits of Artificial Proprioception on Walking Speed and Turning Control in Lower-Limb Amputation. Revista Mexicana de Ingeniería Biomédica. 2026;47(3):e1686. doi:10.17488/rmib.47.3.1686
BibTeX
@article{DiazHernandez2026,
author = {Diaz-Hernandez, Octavio},
title = {Assessing the Benefits of Artificial Proprioception on Walking Speed and Turning Control in Lower-Limb Amputation},
journal = {Revista Mexicana de Ingeniería Biomédica},
year = {2026},
volume = {47},
number = {3},
pages = {e1686},
doi = {10.17488/rmib.47.3.1686}
}
EUVIMED